Same-session dual chromophore riboflavin/UV-A and rose bengal/green light PACK-CXL in Acanthamoeba keratitis: a case report
2025

Dual Chromophore Treatment for Acanthamoeba Keratitis

Sample size: 1 publication Evidence: low

Author Information

Author(s): Farhad Hafezi, Jürg Messerli, Emilio A. Torres-Netto, Nan-Ji Lu, M. Enes Aydemir, Nikki L. Hafezi, Mark Hillen

Primary Institution: ELZA Institute AG

Hypothesis

Can a combined same-session treatment using riboflavin/UV-A and rose bengal/green light effectively treat Acanthamoeba keratitis?

Conclusion

The combined treatment effectively resolved Acanthamoeba keratitis symptoms and showed no detectable cysts after treatment.

Supporting Evidence

  • The patient had active Acanthamoeba keratitis unresponsive to 10 months of conventional treatment.
  • After three treatments, the patient's symptoms resolved and confocal microscopy showed no detectable Acanthamoeba cysts.
  • The treatment approach combines two different light therapies to enhance effectiveness.

Takeaway

Doctors tried a new way to treat a serious eye infection that didn't get better with regular medicine, and it worked really well.

Methodology

The patient underwent three combined same-session PACK-CXL treatments using riboflavin/UV-A and rose bengal/green light.

Limitations

The study lacks a control group and may be influenced by previous treatments.

Participant Demographics

A 44-year-old patient with Acanthamoeba keratitis.

Digital Object Identifier (DOI)

10.1186/s40662-024-00420-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication